Amalgamated Bank Akebia Therapeutics, Inc. Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

A detailed history of Amalgamated Bank transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 7,197 shares of AKBA stock, worth $24,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,197
Previous 7,197 -0.0%
Holding current value
$24,757
Previous $14,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.86 - $1.63 $6,189 - $11,731
7,197 New
7,197 $7,000
Q2 2022

Aug 15, 2022
SELL
$0.32 - $0.67 $7,757 - $16,241
-24,241 Closed
0 $0
Q1 2022

Jun 30, 2022
SELL
$0.72 - $2.93 $1,319 - $5,367
-1,832 Reduced 7.03%
24,241 $17,000
Q4 2021

Feb 15, 2022
BUY
$2.26 - $3.34 $2,350 - $3,473
1,040 Added 4.15%
26,073 $59,000
Q3 2021

Oct 29, 2021
SELL
$2.35 - $3.88 $1,720 - $2,840
-732 Reduced 2.84%
25,033 $72,000
Q2 2021

Aug 16, 2021
BUY
$2.83 - $4.2 $9,568 - $14,200
3,381 Added 15.1%
25,765 $98,000
Q4 2020

Feb 12, 2021
BUY
$2.22 - $3.78 $261 - $446
118 Added 0.53%
22,384 $62,000
Q3 2020

Oct 30, 2020
BUY
$2.39 - $13.08 $3,455 - $18,913
1,446 Added 6.95%
22,266 $56,000
Q2 2020

Aug 10, 2020
BUY
$6.67 - $13.58 $15,967 - $32,510
2,394 Added 12.99%
20,820 $283,000
Q1 2020

May 13, 2020
SELL
$4.1 - $10.24 $3,197 - $7,987
-780 Reduced 4.06%
18,426 $140,000
Q4 2019

Feb 13, 2020
BUY
$3.16 - $6.73 $5,381 - $11,461
1,703 Added 9.73%
19,206 $121,000
Q3 2019

Nov 13, 2019
SELL
$3.55 - $5.4 $745 - $1,134
-210 Reduced 1.19%
17,503 $69,000
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $17,777 - $34,904
4,336 Added 32.41%
17,713 $86,000
Q1 2019

May 15, 2019
BUY
$5.41 - $8.73 $2,369 - $3,823
438 Added 3.39%
13,377 $110,000
Q4 2018

Feb 15, 2019
BUY
$5.39 - $9.15 $69,741 - $118,391
12,939 New
12,939 $72,000

Others Institutions Holding AKBA

# of Institutions
157
Shares Held
96.8M
Call Options Held
98.6K
Put Options Held
320K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $632M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email